Erythropoietin with iron supplementation for preoperative anaemia in non‐cardiac surgery
References
Additional references
Baron, M, Hochrieser B, Posch M, Metnitz B, Rhodes A, Moreno RP, et al. Preoperative anaemia is associated with poor clinical outcome in non‐cardiac surgery patients. British Journal of Anaesthesia 2014;113(3):416‐23. [DOI: 10.1093/bja/aeu098; PUBMED: 24829444]
Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. British Journal of Surgery 1986;73:783‐5. [DOI: 10.1002/bjs.1800731007]
Casalduero VJ, Garcia‐Erce JA, Munoz M. Short term benefit of iron sucrose treatment in patients sustaining hip surgery: reduction of transfusion and infection rates. A meta analysis. Transfusion Alternatives in Transfusion Medicine 2008;10(1):43‐4.
David ML, Estelle SL, Minh‐Ha T. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: A systematic review. Transfusion Medicine Reviews 2013;27:221‐34.
Devon KM, McLeod RS. Pre and peri‐operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007148.pub2]
Feagan BG, Wong CJ, Kirkley A, Johnston DWC, Smith FC, Whitsitt P, et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. Annals of Internal Medicine 2000;133:845‐54. [DOI: 10.7326/0003‐4819‐133‐11‐200012050‐00008; PUBMED: 11103054]
Fisher JW. Erythropoietin: physiology and pharmacology update. Experimental Biology and Medicine 2003;228:1‐14. [PUBMED: 12524467]
Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. British Journal of Anaesthesia 2011;106(1):13‐22. [DOI: 10.1093/bja/aeq361; PUBMED: 21148637]
GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Greinacher A, Fendrich K, Brzenska R, Kiefel V, Hoffmann W. Implications of demographics on future blood supply: a population‐based cross‐sectional study. Transfusion 2011;51(4):702‐9. [DOI: 10.1111/j.1537‐2995.2010.02882.x.; PUBMED: 20849411]
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical research edition) 2008;336(7651):995‐8. [DOI: 10.1136/bmj.39490.551019.BE.; PUBMED: 18456631]
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, BrozekJ, et al. GRADE guidelines: 1. Introduction‐GRADEevidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94. [PUBMED: 21195583]
Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Jans Ø, Jørgensen C, Kehlet H, Johansson PI, Lundbeck Foundation Centre for Fast‐track Hip and Knee Replacement Collaborative Group. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast‐track hip and knee arthroplasty. Transfusion 2014;54:717‐26. [DOI: 10.1111/trf.12332; PUBMED: 23829298]
Jelkmann I, Jelkmann W. Impact of erythropoietin on intensive care unit patients. Transfusion Medicine and Hemotherapy 2013;40(5):310‐8. [DOI: 10.1159/000354128; PUBMED: 24273484]
Khanna MP, Hebert PC, Fergusson DA. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfusion Medicine Reviews 2003;17(2):110‐9. [PUBMED: 12733104]
Kozek‐Langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013;30:270‐382. [DOI: 10.1097/EJA.0b013e32835f4d5b; PUBMED: 23656742]
Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. The Lancet 1993;341:1227‐32. [DOI: 10.1016/0140‐6736(93)91143‐A; PUBMED: 8098389]
Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: A systematic review. Transfusion Medicine Reviews 2013;27:221‐34.
McIntyre L, Hebert PC, Wells G, Fergusson D, Marshall J, Yetisir E, et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?. The Journal of Trauma 2004;57:563‐8. [DOI: 10.1097/01.TA.0000136158.93864.54]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA Statement. Open Medicine 2009;3(3):e123‐30. [PUBMED: 21603045]
Morton J, Anastassopoulos KP, Patel ST, Lerner JH, Ryan KJ, Goss TF, et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. American Journal of Medical Quality 2010;25(4):289‐96. [DOI: 10.1177/1062860610366159; PUBMED: 20530223]
Munoz M, Breymann C, Garcia‐Erce JA, Gomez‐Ramirez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sanguinis 2008;94(3):172‐83. [PUBMED: 18069918]
Muñoz M, García‐Erce JA, Cuenca J, Bisbe E, Naveira E, AWGE (Spanish Anaemia Working Group). On the role of iron therapy for reducing allogenic blood transfusion in orthopaedic surgery. Blood Transfusion 2012;10:8‐22. [DOI: 10.2450/2011.0061‐11; PUBMED: 22153694]
Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non‐cardiac surgery: a retrospective cohort study. The Lancet 2011;378:1396‐407. [DOI: 10.1016/S0140‐6736(11)61381‐0; PUBMED: 21982521]
Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH. Effects of intravenous iron combined with low‐dose recombinant human erythropoietin on transfusion requirements in iron‐deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011;51:118‐24. [DOI: 10.1111/j.1537‐2995.2010.02783.x; PUBMED: 20624257]
NCT00395447. REPLACE: Implantable Cardiac Pulse Generator Registry (REPLACE) [Prospective assessment of the complication rate after device replacement due to ERI, advisory or upgrade]. clinicaltrials.gov/ct2/show/NCT00395447 (first received 1 November 2006).
Ng O, Keeler B, Mishra A, Simpson A, Neal K, Brookes MJ, et al. Iron therapy for pre‐operative anaemia. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD011588.pub2]
Ralley FE. Erythropoietin and intravenous iron in PBM. Transfusion and Apheresis Science 2014;50(1):16‐9. [DOI: 10.1016/j.transci.2013.12.007; PUBMED: 24411666]
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schuenemann HJ. GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2009;103:391‐400.
Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity‐based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753‐65. [DOI: 10.1111/j.1537‐2995.2009.02518.x; PUBMED: 20003061]
Steinbicker AU, Muckenthaler MU. Out of balance‐systemic iron homeostasis in iron‐related disorders. Nutrients 2013;5(8):3024‐61. [DOI: 10.3390/nu5083034; PUBMED: 23917168]
Weber EWG, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). European Journal of Anaesthesiology 2005;22:249‐57. [PUBMED: 15892401]
Weltert L, D'Alessandro S, Nardella S, Girola F, Bellisario A, Maselli D, et al. Preoperative very short‐term, high‐dose erythropoietin administration diminishes blood transfusion rate in off‐pump coronary artery bypass: A randomized blind controlled study. The Journal of Thoracic and Cardiovascular Surgery 2010;139(3):621‐7. [DOI: 10.1016/j.jtcvs.2009.10.012; PUBMED: 20042202]
